Administrative Core
Administrative Core
批准号:
10254245
负责人:
Gary S Gilkeson
金额:
$13.43万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-25 至 2022-09-22
关键词:
Advisory CommitteesAdvocacyAdvocateAfrican AmericanAmericasAppointmentAreaAvena sativaBusinessesClinicalClinical ResearchCollaborationsCollectionCommunicationCommunitiesConflict of InterestDataDiagnosisEffectivenessEnsureEthnic groupEvaluationFacultyFamilyFosteringFoundationsFundingGoalsGrantHealthHealth ProfessionalHuman ResourcesIncidenceIndividualInfrastructureInvestigationIslandKnowledgeLeadLeadershipLupusMeasuresMedicalMentorsMissionMonitorMorbidity - disease rateNational Institute of Arthritis and Musculoskeletal and Skin DiseasesOutcomeOutputPatientsPerformancePilot ProjectsPreventionPrevention strategyProblem SolvingProductivityRaceReportingResearchResearch ActivityResearch InstituteResearch PersonnelResource SharingResourcesRheumatismRiskSamplingScientistSclerodermaSeaServicesSeveritiesSilverSouth CarolinaSystemic Lupus ErythematosusSystemic SclerodermaTimeTranslational ResearchTravelUnderrepresented MinorityUnited StatesUniversitiesUpdateclinical careclinical centerdesignexperiencefollow-uphealth disparityimprovedinnovationmeetingsmemberminority healthminority investigatoroperationoutreachprogramsresearch studyshared databasetoolweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The Administrative Core of the Core Center for Clinical Research (CCCR) for Improving Minority Health in
Rheumatic Diseases (IMHRD, pronounced IaMHeaRD) at the Medical University of South Carolina will provide
leadership and management for the center and implement a pilot projects program that will be funded entirely
with institutional commitments. The mission of this CCCR is to advance knowledge with respect to the clinical
care and health outcomes of African Americans who have, or who are at risk of developing, systemic lupus
erythematosus, scleroderma and other debilitating rheumatic diseases. The overarching goals of the
Administrative Core are to: (a) ensure the quality, validity, accessibility and applicability of the tools, services,
samples, data and other output of the CCCR cores, (b) foster interactions among basic, translational and clinical
scientists at MUSC and beyond to focus effectively on advancing prevention, diagnosis and treatment of
rheumatic diseases, and (c) facilitate appropriate dissemination of research results and resources. To achieve
these goals, we will pursue the following specific aims: 1. Provide leadership for the CCCR; 2. Coordinate and
manage CCCR organizational, operational and financial functions and evaluative activities; 3. Leverage
institutional infrastructure resources; 4. Develop and manage a multi-year Evaluation Plan; 5. Strengthen and
expand robust, effective communication, dissemination and outreach activities, fostering mutually productive
interactions among members of health professional, scientific and citizen communities; and 6. Provide a
competitive Pilot Projects Program. This core will be directed by Gary Gilkeson, MD, with assistance from two
Associate Directors, Jim Oates, MD, and Richard Silver, MD, an Executive Committee that includes core leaders
and Research Community representatives, an Internal Advisory Committee that includes institutional
stakeholders and patient advocates, and an External Advisory Committee that includes experts in the field with
experience leading other NIAMS centers. The Administrative Core staff will provide administrative support for
the center, administering and monitoring the finances, coordinating meetings and action items, and interfacing
with NIAMS staff and institutional personnel. The Administrative Core also will support educational and
dissemination activities to enhance the visibility and impact of the center within MUSC and the local community
and provide a forum for communicating and exchanging research ideas. The Administrative Core will nurture a
vibrant, interactive program of clinical and translational research that will advance our knowledge and resources
for improving the prevention, diagnosis, treatment and health outcomes for rheumatic diseases, notably systemic
lupus erythematosus (SLE) and systemic sclerosis (SSc), which occur significantly more often and with greater
severity in African Americans than in other racial and ethnic groups in the United States.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus
-
批准号:10827646
-
项目类别:
-
资助金额:$46.44万
-
财政年份:2018
-
负责人:Gary S Gilkeson
-
依托单位:
A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus
-
批准号:10356843
-
项目类别:
-
资助金额:$70.78万
-
财政年份:2018
-
负责人:Gary S Gilkeson
-
依托单位:
Improving Minority Health in Rheumatic Diseases
-
批准号:9902868
-
项目类别:
-
资助金额:$55.05万
-
财政年份:2017
-
负责人:Gary S Gilkeson
-
依托单位:
Improving Minority Health in Rheumatic Diseases
-
批准号:10254241
-
项目类别:
-
资助金额:$70.51万
-
财政年份:2017
-
负责人:Gary S Gilkeson
-
依托单位:
Improving Minority Health in Rheumatic Diseases
-
批准号:9413805
-
项目类别:
-
资助金额:$74.46万
-
财政年份:2017
-
负责人:Gary S Gilkeson
-
依托单位:
Role of Gut Microbial Translocation in Initiating Autoimmunity
-
批准号:10291780
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Gary S Gilkeson
-
依托单位:
Role of Gut Microbial Translocation in Initiating Autoimmunity
-
批准号:9564333
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Gary S Gilkeson
-
依托单位:
Mesenchymal Stem Cell Therapy for Active Systemic Lupus Erythematosus
-
批准号:8791443
-
项目类别:
-
资助金额:$25.51万
-
财政年份:2014
-
负责人:Gary S Gilkeson
-
依托单位:
Sex Differences in Gut Permeability; Impact on Autoimmunity
-
批准号:8958705
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Gary S Gilkeson
-
依托单位:
Sex Differences in Gut Permeability; Impact on Autoimmunity
-
批准号:8820340
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Gary S Gilkeson
-
依托单位:
Sex Differences in Gut Permeability; Impact on Autoimmunity
-
批准号:9274921
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Gary S Gilkeson
-
依托单位:
Role of Gut Microbial Translocation in Initiating Autoimmunity
-
批准号:10426227
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Gary S Gilkeson
-
依托单位:
Role of Gut Microbial Translocation in Initiating Autoimmunity
-
批准号:9838084
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Gary S Gilkeson
-
依托单位:
MCRC for Rheumatic Diseases in African Americans
-
批准号:9133270
-
项目类别:
-
资助金额:$115.83万
-
财政年份:2012
-
负责人:Gary S Gilkeson
-
依托单位:
MCRC for Rheumatic Diseases in African Americans
-
批准号:8493999
-
项目类别:
-
资助金额:$109.55万
-
财政年份:2012
-
负责人:Gary S Gilkeson
-
依托单位:
MCRC for Rheumatic Diseases in African Americans
-
批准号:8712778
-
项目类别:
-
资助金额:$9.99万
-
财政年份:2012
-
负责人:Gary S Gilkeson
-
依托单位:
MCRC for Rheumatic Diseases in African Americans
-
批准号:8699679
-
项目类别:
-
资助金额:$111.46万
-
财政年份:2012
-
负责人:Gary S Gilkeson
-
依托单位:
MCRC for Rheumatic Diseases in African Americans
-
批准号:8290590
-
项目类别:
-
资助金额:$116.94万
-
财政年份:2012
-
负责人:Gary S Gilkeson
-
依托单位:
Role of Estrogen Receptors in Lupus-Modulators of the Inflammatory Response
-
批准号:8195560
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Gary S Gilkeson
-
依托单位:
Role of Estrogen Receptors in Lupus-Modulators of the Inflammatory Response
-
批准号:7787999
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Gary S Gilkeson
-
依托单位:
海外基金